Last reviewed · How we verify

Intraoperative Intravenous Lidocaine Infusion

McMaster University · Phase 3 active Small molecule

Intraoperative Intravenous Lidocaine Infusion is a Local anesthetic / Sodium channel blocker Small molecule drug developed by McMaster University. It is currently in Phase 3 development for Perioperative pain management and opioid reduction in surgical patients, Postoperative recovery enhancement. Also known as: Xylocaine.

Lidocaine blocks sodium channels in nerve fibers, reducing pain signal transmission and providing local anesthetic and analgesic effects during surgery.

Lidocaine blocks sodium channels in nerve fibers, reducing pain signal transmission and providing local anesthetic and analgesic effects during surgery. Used for Perioperative pain management and opioid reduction in surgical patients, Postoperative recovery enhancement.

At a glance

Generic nameIntraoperative Intravenous Lidocaine Infusion
Also known asXylocaine
SponsorMcMaster University
Drug classLocal anesthetic / Sodium channel blocker
TargetVoltage-gated sodium channels
ModalitySmall molecule
Therapeutic areaPerioperative pain management / Surgery
PhasePhase 3

Mechanism of action

Intravenous lidocaine infusion during surgery works by blocking voltage-gated sodium channels in peripheral nerves and the central nervous system, which suppresses pain signal conduction. This perioperative approach aims to reduce postoperative pain, opioid consumption, and potentially improve recovery outcomes. The mechanism also includes anti-inflammatory and immunomodulatory effects that may contribute to reduced surgical stress response.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Intraoperative Intravenous Lidocaine Infusion

What is Intraoperative Intravenous Lidocaine Infusion?

Intraoperative Intravenous Lidocaine Infusion is a Local anesthetic / Sodium channel blocker drug developed by McMaster University, indicated for Perioperative pain management and opioid reduction in surgical patients, Postoperative recovery enhancement.

How does Intraoperative Intravenous Lidocaine Infusion work?

Lidocaine blocks sodium channels in nerve fibers, reducing pain signal transmission and providing local anesthetic and analgesic effects during surgery.

What is Intraoperative Intravenous Lidocaine Infusion used for?

Intraoperative Intravenous Lidocaine Infusion is indicated for Perioperative pain management and opioid reduction in surgical patients, Postoperative recovery enhancement.

Who makes Intraoperative Intravenous Lidocaine Infusion?

Intraoperative Intravenous Lidocaine Infusion is developed by McMaster University (see full McMaster University pipeline at /company/mcmaster-university).

Is Intraoperative Intravenous Lidocaine Infusion also known as anything else?

Intraoperative Intravenous Lidocaine Infusion is also known as Xylocaine.

What drug class is Intraoperative Intravenous Lidocaine Infusion in?

Intraoperative Intravenous Lidocaine Infusion belongs to the Local anesthetic / Sodium channel blocker class. See all Local anesthetic / Sodium channel blocker drugs at /class/local-anesthetic-sodium-channel-blocker.

What development phase is Intraoperative Intravenous Lidocaine Infusion in?

Intraoperative Intravenous Lidocaine Infusion is in Phase 3.

What are the side effects of Intraoperative Intravenous Lidocaine Infusion?

Common side effects of Intraoperative Intravenous Lidocaine Infusion include Dizziness or lightheadedness, Nausea, Tinnitus, Perioral numbness, Cardiac arrhythmias (at high doses).

What does Intraoperative Intravenous Lidocaine Infusion target?

Intraoperative Intravenous Lidocaine Infusion targets Voltage-gated sodium channels and is a Local anesthetic / Sodium channel blocker.

Related